Mayer-Hamblett N - Search Results

1

Systematic review of blood biomarkers in cystic fibrosis pulmonary exacerbations.

Shoki AH, Mayer-Hamblett N, Wilcox PG, Sin DD, Quon BS. Shoki AH, et al. Chest. 2013 Nov;144(5):1659-1670. doi: 10.1378/chest.13-0693. Chest. 2013. PMID: 23868694 Review.

2

Susceptibility testing of Pseudomonas aeruginosa isolates and clinical response to parenteral antibiotic administration: lack of association in cystic fibrosis.

Smith AL, Fiel SB, Mayer-Hamblett N, Ramsey B, Burns JL. Smith AL, et al. Chest. 2003 May;123(5):1495-502. doi: 10.1378/chest.123.5.1495. Chest. 2003. PMID: 12740266

3

Laboratory parameter profiles among patients with cystic fibrosis.

Goss CH, Mayer-Hamblett N, Kronmal RA, Williams J, Ramsey BW. Goss CH, et al. J Cyst Fibros. 2007 Apr;6(2):117-23. doi: 10.1016/j.jcf.2006.05.012. Epub 2006 Jul 7. J Cyst Fibros. 2007. PMID: 16829217 Free article.

4

Association between pulmonary function and sputum biomarkers in cystic fibrosis.

Mayer-Hamblett N, Aitken ML, Accurso FJ, Kronmal RA, Konstan MW, Burns JL, Sagel SD, Ramsey BW. Mayer-Hamblett N, et al. Am J Respir Crit Care Med. 2007 Apr 15;175(8):822-8. doi: 10.1164/rccm.200609-1354OC. Epub 2007 Jan 18. Am J Respir Crit Care Med. 2007. PMID: 17234902 Free PMC article.

5

Advancing outcome measures for the new era of drug development in cystic fibrosis.

Mayer-Hamblett N, Ramsey BW, Kronmal RA. Mayer-Hamblett N, et al. Proc Am Thorac Soc. 2007 Aug 1;4(4):370-7. doi: 10.1513/pats.200703-040BR. Proc Am Thorac Soc. 2007. PMID: 17652504 Free PMC article. Review.

6

Shifting patterns of inhaled antibiotic use in cystic fibrosis.

Moskowitz SM, Silva SJ, Mayer-Hamblett N, Pasta DJ, Mink DR, Mabie JA, Konstan MW, Wagener JS; Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis (ESCF). Moskowitz SM, et al. Pediatr Pulmonol. 2008 Sep;43(9):874-81. doi: 10.1002/ppul.20873. Pediatr Pulmonol. 2008. PMID: 18668689

7

Reproducibility of spirometry during cystic fibrosis pulmonary exacerbations.

Sanders DB, Rosenfeld M, Mayer-Hamblett N, Stamey D, Redding GJ. Sanders DB, et al. Pediatr Pulmonol. 2008 Nov;43(11):1142-1146. doi: 10.1002/ppul.20924. Pediatr Pulmonol. 2008. PMID: 18846562

8

Risk factors for chronic kidney disease in adults with cystic fibrosis.

Quon BS, Mayer-Hamblett N, Aitken ML, Smyth AR, Goss CH. Quon BS, et al. Am J Respir Crit Care Med. 2011 Nov 15;184(10):1147-52. doi: 10.1164/rccm.201105-0932OC. Epub 2011 Jul 28. Am J Respir Crit Care Med. 2011. PMID: 21799076 Free PMC article.

9

Risk of post-lung transplant renal dysfunction in adults with cystic fibrosis.

Quon BS, Mayer-Hamblett N, Aitken ML, Goss CH. Quon BS, et al. Chest. 2012 Jul;142(1):185-191. doi: 10.1378/chest.11-1926. Chest. 2012. PMID: 22222189 Free PMC article.

10

Effect of azithromycin on systemic markers of inflammation in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa.

Ratjen F, Saiman L, Mayer-Hamblett N, Lands LC, Kloster M, Thompson V, Emmett P, Marshall B, Accurso F, Sagel S, Anstead M. Ratjen F, et al. Chest. 2012 Nov;142(5):1259-1266. doi: 10.1378/chest.12-0628. Chest. 2012. PMID: 22595153 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

131 results

Search Page

Filters